ALKEM - IntraDay Trade Analysis with Live Signals
Back to ListIntraDay Trade Rating: 3.8
| Stock Code | ALKEM | Market Cap | 64,238 Cr. | Current Price | 5,372 ₹ | High / Low | 5,934 ₹ |
| Stock P/E | 27.9 | Book Value | 1,171 ₹ | Dividend Yield | 0.84 % | ROCE | 19.9 % |
| ROE | 17.5 % | Face Value | 2.00 ₹ | DMA 50 | 5,402 ₹ | DMA 200 | 5,433 ₹ |
| Chg in FII Hold | 0.18 % | Chg in DII Hold | -0.15 % | PAT Qtr | 294 Cr. | PAT Prev Qtr | 654 Cr. |
| RSI | 50.2 | MACD | -26.2 | Volume | 77,370 | Avg Vol 1Wk | 74,295 |
| Low price | 4,716 ₹ | High price | 5,934 ₹ | PEG Ratio | 1.06 | Debt to equity | 0.04 |
| 52w Index | 53.9 % | Qtr Profit Var | 30.2 % | EPS | 191 ₹ | Industry PE | 32.1 |
📊 Optimal Buy Price: 5,350–5,380 ₹ (near DMA 50 support)
💹 Profit-Taking Levels: 5,450–5,520 ₹ (short-term resistance zone)
🛑 Stop-Loss: 5,320 ₹
⏱️ Exit Strategy if Holding: Exit intraday if RSI falls below 48 or price fails to sustain above 5,350 ₹. Book profits if momentum drives price into 5,450–5,520 ₹ zone with strong volume confirmation. Exit early if intraday volume weakens below average and price slips under 5,350 ₹.
✅ Positive
- Strong ROCE (19.9%) and ROE (17.5%) indicate efficient capital use
- EPS at 191 ₹ supports long-term fundamentals
- Debt-to-equity ratio at 0.04 — very low leverage
- FII holding increased (+0.18%) showing foreign investor confidence
- Price trading near DMA 50 (5,402 ₹) and DMA 200 (5,433 ₹), providing technical support
- Dividend yield of 0.84% adds stability
⚠️ Limitation
- Quarterly PAT declined (294 Cr. vs 654 Cr.), showing short-term weakness
- DII holding decreased (-0.15%) showing mixed institutional sentiment
- MACD negative (-26.2) indicates bearish bias
- RSI at 50.2 suggests neutral momentum, not strongly bullish
- PEG ratio at 1.06 indicates moderate overvaluation relative to growth
📉 Company Negative News
- No major negative news reported, but profit decline and valuation concerns persist
📈 Company Positive News
- Strong fundamentals with high EPS and efficient capital returns
- Dividend yield provides investor confidence
- Technical support near DMA 50 and DMA 200 offers favorable entry zone
🏭 Industry
- Pharmaceutical sector benefiting from consistent demand and innovation
- Peers trading at similar valuations, making ALKEM moderately priced
🔎 Conclusion
ALKEM shows moderate intraday potential with strong fundamentals, low debt, and supportive technical levels. However, declining profits, neutral RSI, and negative MACD limit upside momentum. Suitable for cautious intraday buy near 5,350–5,380 ₹ with strict stop-loss at 5,320 ₹ and profit booking around 5,450–5,520 ₹.
For deeper context, you could expand this into a swing trade outlook, add sector overlays, or run a peer benchmarking to evaluate ALKEM against its industry peers.